Grace Park
About Grace Park
Grace H. Park is Executive Vice President & General Counsel of Public Service Enterprise Group (PSEG), appointed effective September 16, 2024; she oversees legal and federal regulatory strategy and the Corporate Secretary, Litigation, Compliance and Claims functions . She is 49 years old and joined PSEG in 2017 after prior roles as Acting Prosecutor in Union County, NJ, Senior Corporate Counsel at Pfizer, and a federal prosecutor in the U.S. Attorney’s Office in Newark; she holds degrees from UC Berkeley and Harvard Law School . Company performance relevant to incentive design includes top-quartile TSR and ROIC outcomes in the 2022 PSU cycle (163% payout) and 2024 operating earnings (non-GAAP) growth to $1,839 million amid lower operating revenues, reflecting alignment of pay with long-term metrics .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| PSEG Services/PSEG | EVP & General Counsel | Sep 2024–present | Oversees overall legal and federal regulatory strategy; directs Corporate Secretary, Litigation, Compliance, and Claims . |
| PSEG Services | VP, Deputy General Counsel & Chief Litigation Counsel | 2020–Sep 2024 | Led litigation and government inquiries; oversaw claims processes including recovery and relocation . |
| PSEG (enterprise) | Joined PSEG | 2017 | Brought prosecutorial and corporate litigation expertise to build internal legal capabilities . |
External Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Union County, NJ | Acting Prosecutor | ~4 years (pre-2017) | Led county-level prosecutions and enforcement strategy . |
| Pfizer Inc. | Senior Corporate Counsel (Litigation) | n/a (pre-2017) | Managed complex corporate litigation matters . |
| U.S. Attorney’s Office, Newark | Federal Prosecutor | n/a (pre-2017) | Prosecuted federal cases; developed litigation and compliance rigor . |
| Education | UC Berkeley; Harvard Law School | n/a | Academic credentials underpin legal leadership . |
Fixed Compensation
| Component | Terms | Dates/Amounts | Notes |
|---|---|---|---|
| Base Salary | EVP & General Counsel | $650,000 base, effective Sep 16, 2024 | Annual review beginning Jan 2025 . |
| Target Annual Bonus (MICP) | Target % of base | 75% target (prorated for 2024 across pre/post-promotion periods) | 2024 award prorated: 50% target on pre-promotion VP salary Jan 1–Sep 15; 75% target on EVP salary Sep 16–Dec 31 . |
| Long-Term Incentive (LTIP) | RSUs + PSUs | 2024 total $600,000 (incl. $300k supplemental); 30% RSUs / 70% PSUs | RSUs graded vesting over 3 years; PSUs 3-year performance period ending Dec 31, 2026, payout the following year . |
| Vehicle Stipend | Monthly cash stipend | $1,000/month starting Oct 2024 | For vehicle costs; subject to program terms . |
| Deferred Compensation Eligibility | Base pay and MICP | Eligible to defer base and/or MICP; DCP amended Nov 18, 2024 to expand/core contributions | Plan amendments broaden eligibility to certain highly-compensated non-officers and clarify governance . |
Performance Compensation
| Metric | Weighting | Target Definition | Actual Outcome | Payout Factor | Vesting |
|---|---|---|---|---|---|
| Total Shareholder Return (PSU) | 40% | Peer-relative percentile: 50th=100%; >75th=200%; 25th=20% | Top quartile | 200% | PSUs cliff vest after 3-year period; retirement-eligible participants vest 1/36 per month; 2022 cycle paid 163% overall . |
| ROIC (PSU) | 20% | Peer-relative percentile as above | Top quartile | 200% | As above . |
| EPS Growth (PSU) | 20% | Operating EPS in year 3; guidance supports 5–7% CAGR | Low end of 5–7% target range; exceeded 2024 EPS target | 69% | As above . |
| ESG Index (PSU) | 20% | EE electric/gas savings, methane reductions, carbon-free generation, Sustainalytics risk | High-end targets met; top quartile risk rating | 148% | As above . |
| MICP (Annual Cash) | n/a | Emphasizes Operating EPS (non-GAAP), business scorecards, operational/people metrics; 0–200% payout scale | Determined annually per plan | Company-wide design; individual payout depends on goals | Paid in following year per plan mechanics . |
Reference company performance: Operating revenues $10,290m (2024) vs $11,237m (2023); operating earnings (non-GAAP) $1,839m (2024) vs $1,742m (2023), reflecting incentive emphasis on operating EPS .
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Officer Stock Ownership Guideline | Required minimum 4× base salary for EVP & General Counsel; effective Jan 1, 2025; 5 years to reach compliance (by Jan 1, 2030) . |
| Hedging/Pledging | Prohibited for all employees, officers, and directors; includes short sales, puts/calls, collars, margin purchases, and pledging; 10b5-1 plan exception for exercise/hold per policy . |
| Trading Controls | Mandatory pre-clearance for directors/officers; quarterly blackout from close on 15th of quarter-end month through first business day after 10-Q/10-K filing; 10b5-1 plan governance . |
| Deferred Equity | Eligible to defer RSUs/PSUs under Equity Deferral Plan during open enrollment . |
| Beneficial Ownership Activity | Form 4 filed Feb 12, 2025 (phantom stock/administrative transaction) . Form 4 filed Sep 17, 2025 reflecting sale of 131 PEG shares on Sep 16, 2025 at $83.21 (and correction of 5 omitted shares) . |
| Pledging Status | Company policy prohibits pledging; no pledging disclosed in proxy or policies . |
Employment Terms
| Term | Provision |
|---|---|
| Appointment & Role | Appointed EVP & General Counsel effective Sep 16, 2024; succession from EVP & GC; Ms. Linde served as EVP & Chief Legal Officer through Mar 14, 2025 . |
| Offer Letter & Designations | EVP base $650,000; 75% MICP target; 2024 LTIP total $600,000 (30% RSUs/70% PSUs); vehicle stipend $1,000/mo; designated Schedule A participant under Key Executive Severance Plan; ownership guideline 4× salary; non-compete, non-solicit, confidentiality, arbitration required . |
| Severance (No CIC) | Lump sum cash: base salary through termination + 1.0× (0.5× if <1 year tenure) sum of Annual Base Salary + Target Bonus; prorated annual incentive at 100% target; outplacement up to $25,000; education assistance; LTIP awards per plan terms . |
| Change-in-Control (CIC) | Double-trigger. For Schedule A participants: 2× sum of Annual Base Salary + Target Bonus; prorated target bonus; accelerated vesting of equity awards (PSUs prorated based on actual performance); nonqualified pension enhancement (2 years for Schedule A); continued welfare benefits; outplacement up to $25,000; vesting of deferred comp; payments capped to avoid 280G excise tax; no gross-ups . |
| Clawbacks | Robust clawback practices: 3-year look-back for misconduct or Standards violations; Dodd-Frank/NYSE-compliant recovery of erroneously awarded executive incentive compensation on restatement (fault-agnostic) . |
| Trading Governance | Pre-clearance required; quarterly blackout; hard-ships waivers at GC discretion; comprehensive officer pre-clearance process (RTT form, SO&R compliance checks) . |
Investment Implications
- Alignment and retention: A stringent 4× salary stock ownership requirement and hedging/pledging prohibitions underpin long-term alignment; five-year compliance window (to Jan 1, 2030) reduces forced insider selling, while pre-clearance/blackouts mitigate trading risk signals .
- Severance economics: Schedule A double-trigger CIC benefits (2× base+bonus plus equity/benefit treatment, capped to avoid excise tax) support stability in change events without gross-ups; outside CIC severance at 1.0× base+bonus with prorated incentive is shareholder-favorable versus typical utilities peers .
- Pay-for-performance: LTIP structure weighted to PSUs (70%) with TSR/ROIC/EPS/ESG metrics and demonstrated 163% payout for the 2022 cycle signals strong past execution; annual MICP tied to Operating EPS and scorecards aligns cash incentives with operating performance, with 2024 operating earnings growth despite revenue decline .
- Insider activity: Limited Form 4 selling (e.g., 131 shares at $83.21 on Sep 16, 2025) and administrative phantom stock transactions suggest low selling pressure; policy controls reduce potential adverse signals and timing risks .